KeyMed Biosciences (2162.HK) Stock Price
KeyMed Biosciences Price
Over the last 4 years KeyMed Biosciences grew revenue by 58.6% annually, reaching 813.73 M CNY. For KeyMed Biosciences, the net margin of -73.0% is up versus -3,535.4% a few years ago. The consensus 12-month price target for KeyMed Biosciences is 72.43 CNY, about 4.2% above where the stock trades today. Of 18 analysts, 17 rate the stock a buy — an overall Buy consensus.
KeyMed Biosciences stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
KeyMed Biosciences business model & stock analysis
Frequently asked questions about KeyMed Biosciences
Analysts currently set an average price target of 72.51 CNY for the KeyMed Biosciences stock (median: 72.43 CNY), implying +5.0 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the KeyMed Biosciences stock: 17 recommend buying, 1 holding and 0 selling. For 2026, analysts expect KeyMed Biosciences to generate revenue of 1.47 B CNY and earnings per share of 3.32 CNY.
Converted at the current exchange rate, the KeyMed Biosciences share trades at 9.30 EUR (69.52 CNY).
The KeyMed Biosciences share (2162.HK) is listed on 3 stock exchanges, including: Hongkong (HKEX) (2162.HK), Frankfurt (64Z.F), Düsseldorf (64Z.DU).
The expected revenue of KeyMed Biosciences is 1.47 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of KeyMed Biosciences is 990.96 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of KeyMed Biosciences is currently 20.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the KeyMed Biosciences stock.
The price-to-sales ratio (P/S) of KeyMed Biosciences is currently 14.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the KeyMed Biosciences stock.
The Eulerpool Quality Score for KeyMed Biosciences is 3/10.
The ISIN of KeyMed Biosciences is KYG5252B1023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of KeyMed Biosciences is A3CTJD. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of KeyMed Biosciences is 2162.HK. The ticker symbol is used to trade KeyMed Biosciences shares on the stock exchange.
KeyMed Biosciences stock
KeyMed Biosciences Peer Group
KeyMed Biosciences Ticker
KeyMed Biosciences FIGI
All fundamentals and in-depth analysis of KeyMed Biosciences
Our stock analysis for KeyMed Biosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KeyMed Biosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.